{"id":"W2947469974","doi":"10.1200/jco.2019.37.15_suppl.500","title":"Neoadjuvant trastuzumab (H), pertuzumab (P), and chemotherapy versus trastuzumab emtansine (T-DM1) and P in human epidermal growth factor receptor 2 (HER2)-positive breast cancer (BC): Final outcome results from the phase III KRISTINE study.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Pertuzumab; Trastuzumab; Internal medicine; Oncology; Trastuzumab emtansine; Taxane; Docetaxel; Breast cancer; Regimen; Chemotherapy; Carboplatin; Cancer; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001397014,0.0006539504,0.001033634,0.0002186501,0.0002211797,0.0006270838,0.0006386455,0.0006749868,0.001792981],"category_scores_gemma":[0.001053018,0.0002925422,0.001112766,0.0002858325,0.0004868711,0.0005988634,0.0002778534,0.001509869,0.0002778603],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001140778,"about_ca_system_score_gemma":0.001040981,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001156694,"about_ca_topic_score_gemma":0.005554013,"domain_scores_codex":[0.9994656,0.0003028519,0.00003985925,0.00007128022,0.00005360401,0.00006670993],"domain_scores_gemma":[0.9991326,0.0002286003,0.0002857439,0.00006832738,0.00004070842,0.0002440491],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9131187,0.01182788,0.007604721,0.0005471834,0.001986604,0.00005948426,0.0001141923,0.001601061,0.007644161,0.0001029116,0.001298433,0.05409472],"study_design_scores_gemma":[0.4510457,0.4870785,0.04391596,0.0001362259,0.00525406,0.0003292261,0.0001470464,0.001748985,0.006612164,0.0002398632,0.003437153,0.00005509729],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950688,0.002874717,0.0001669324,0.0001950533,0.00004805362,0.0003147062,0.0004077091,0.0000155896,0.0009084744],"genre_scores_gemma":[0.9950342,0.001748081,0.0005006816,0.00029931,0.00008509013,0.0003112583,0.0008829354,0.000008732669,0.001129667],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001792981,"threshold_uncertainty_score":0.008276939,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1762928152899336,"score_gpt":0.5137821301172162,"score_spread":0.3374893148272826,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}